{"id":8038,"date":"2020-01-14T13:50:19","date_gmt":"2020-01-14T18:50:19","guid":{"rendered":"http:\/\/localhost:10028\/uncategorized\/new-findings-on-effectiveness-of-hpv-vaccine\/"},"modified":"2020-01-14T13:50:19","modified_gmt":"2020-01-14T18:50:19","slug":"hpv-asisinin-etkinligi-on-yeni-bulgular","status":"publish","type":"post","link":"https:\/\/napolilaw.lemonadestand.org\/tr\/article\/hpv-asisinin-etkinligi-on-yeni-bulgular\/","title":{"rendered":"HPV A\u015f\u0131s\u0131n\u0131n Etkinli\u011fine \u0130li\u015fkin Yeni Bulgular"},"content":{"rendered":"<p>Yeni bir \u00e7al\u0131\u015fma, HPV a\u015f\u0131s\u0131n\u0131n etkinli\u011finin al\u0131nan doz say\u0131s\u0131yla \u00e7ok az ilgisi oldu\u011funu \u00f6ne s\u00fcr\u00fcyor.<\/p>\n<p>\u00d6nerilen seri her zaman iki veya \u00fc\u00e7 doz olmu\u015ftur, ancak <a href=\"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2757996\" target=\"_blank\" rel=\"noopener\">t\u0131p dergisi JAMA Network Open&#039;da yay\u0131nlanan bir \u00e7al\u0131\u015fma<\/a> herhangi bir dozun hi\u00e7 olmamas\u0131ndan daha iyi oldu\u011funu \u00f6ne s\u00fcr\u00fcyor.<\/p>\n<p>\u0130nsanlar\u0131n tek bir doza g\u00fcvenmeleri i\u00e7in hen\u00fcz \u00e7ok erken olsa da, sonu\u00e7lar daha fazla ara\u015ft\u0131rmaya yol a\u00e7acak ve a\u015f\u0131n\u0131n daha fazla insana ula\u015fmas\u0131n\u0131n \u00f6n\u00fcn\u00fc a\u00e7abilir.<\/p>\n<p>Bu hayat kurtar\u0131c\u0131 olabilir.<\/p>\n<p>\u00c7al\u0131\u015fma, 2009 ila 2016 HPV a\u015f\u0131lama ve test anketi verilerini kullanarak 18 ila 26 ya\u015f\u0131ndaki ABD&#039;li kad\u0131nlar\u0131 inceledi.<\/p>\n<p>\u00c7al\u0131\u015fma, hastal\u0131\u011fa yakalanmada bir doz, iki doz veya \u00fc\u00e7 doz alanlar aras\u0131nda anlaml\u0131 bir fark olmad\u0131\u011f\u0131n\u0131 buldu.<\/p>\n<p>Bir doz alan kad\u0131nlar, iki veya \u00fc\u00e7 doz alan kad\u0131nlar kadar korunmu\u015ftur. Herhangi bir doz a\u015f\u0131 alan kad\u0131nlar\u0131n HPV&#039;ye yakalanma olas\u0131l\u0131\u011f\u0131, a\u015f\u0131lanmam\u0131\u015f kad\u0131nlara g\u00f6re daha d\u00fc\u015f\u00fckt\u00fc.<\/p>\n<p>\u0130nsan papilloma vir\u00fcs\u00fc anlam\u0131na gelen HPV, kansere yol a\u00e7abilen cinsel yolla bula\u015fan bir enfeksiyondur.<\/p>\n<p>T\u00fcm servikal ve anal kanserlerin 90%&#039;sini, t\u00fcm penis kanserlerinin 60%&#039;sinden fazlas\u0131n\u0131 ve t\u00fcm oral kanserlerin yakla\u015f\u0131k 70%&#039;sini olu\u015fturur. Vir\u00fcs ta\u015f\u0131yan biriyle genitalden genitale veya a\u011f\u0131zdan genitale temas yoluyla bula\u015f\u0131r.<\/p>\n<p>200&#039;den fazla vir\u00fcs t\u00fcr\u00fc vard\u0131r ve yakla\u015f\u0131k 40 tanesi cinsel organlar\u0131n\u0131za bula\u015f\u0131r.<\/p>\n<p>Genital HPV enfeksiyonlar\u0131 son derece yayg\u0131nd\u0131r ve cinsel a\u00e7\u0131dan aktif ki\u015filerin \u00e7o\u011fu, hayatlar\u0131n\u0131n bir noktas\u0131nda hastal\u0131\u011fa yakalan\u0131r.<\/p>\n<p>\u015eu anda yakla\u015f\u0131k 80 milyon Amerikal\u0131, yakla\u015f\u0131k d\u00f6rtte biri HPV&#039;ye sahip. \u00c7o\u011fu insan, genellikle semptomsuz oldu\u011fu i\u00e7in ona yakaland\u0131klar\u0131n\u0131n fark\u0131na varmaz.<\/p>\n<p>Genital si\u011fillere iki t\u00fcr HPV neden olur ve \u00e7ok rahats\u0131z olmalar\u0131na ra\u011fmen doktor taraf\u0131ndan kolayca \u00e7\u0131kar\u0131labilirler ve neyse ki kansere yol a\u00e7mazlar.<\/p>\n<p>HPV tipik olarak iki y\u0131l i\u00e7inde kendili\u011finden ge\u00e7er. \u00c7o\u011fu su\u015f, herhangi bir t\u0131bbi tedavi olmaks\u0131z\u0131n kal\u0131c\u0131 olarak kaybolur.<\/p>\n<p>Genellikle zarars\u0131z olmas\u0131na ra\u011fmen, servikal, anal, penil, vajinal, vulvar veya a\u011f\u0131z ve g\u0131rtlak kanserine yol a\u00e7abilen yakla\u015f\u0131k bir d\u00fczine vir\u00fcs t\u00fcr\u00fc, \u00f6zellikle de 16 ve 18 t\u00fcrleri vard\u0131r.<\/p>\n<p>\u0130lk enfeksiyondan sonra kanserin geli\u015fmesi y\u0131llar veya on y\u0131llar alabilir.<\/p>\n<p>Ki\u015finin HPV durumunu \u00f6\u011frenecek testler olmamas\u0131na ve HPV&#039;nin tedavisi olmamas\u0131na ra\u011fmen, d\u00fczenli kanser ve Pap testleri doktorun kanseri tedavi edilebilir oldu\u011funda erken evrelerinde yakalamas\u0131n\u0131 sa\u011flayabilir.<\/p>\n<p>Rahim a\u011fz\u0131 kanseri taramas\u0131 30 ya\u015f\u0131n \u00fczerindeki kad\u0131nlara \u00f6nerilir, ancak \u015fu anda erkeklerde HPV taramas\u0131 yapman\u0131n bir yolu yoktur.<\/p>\n<p>Erken m\u00fcdahale \u00e7ok \u00f6nemlidir, bu nedenle cinsel organlar\u0131n\u0131zda herhangi bir anormal cilt b\u00fcy\u00fcmesi veya de\u011fi\u015fiklik fark ederseniz hemen bir doktora g\u00f6r\u00fcn\u00fcn.<\/p>\n<p>Kendinizi HPV&#039;den koruman\u0131n en etkili yolu a\u015f\u0131 olmakt\u0131r. Yayg\u0131n olarak Gardasil 9 olarak bilinen a\u015f\u0131, kansere neden olan HPV su\u015flar\u0131 16 ve 18&#039;e ve genital si\u011fillerin \u00e7o\u011funa neden olan tip 6 ve 11&#039;e kar\u015f\u0131 koruma sa\u011flar.<\/p>\n<p>A\u015f\u0131, vir\u00fcs\u00fcn t\u00fcm su\u015flar\u0131na kar\u015f\u0131 koruma sa\u011flamaz, bu nedenle a\u015f\u0131 olanlar\u0131n \u00e7o\u011fu yine de enfekte olur. A\u015f\u0131, kansere neden olan HPV su\u015flar\u0131na kar\u015f\u0131 koruma sa\u011flamada ba\u015far\u0131l\u0131d\u0131r.<\/p>\n<p>A\u015f\u0131, 12 ila 45 ya\u015flar\u0131 aras\u0131ndaki kad\u0131n ve erkekler i\u00e7in mevcuttur. CDC, k\u0131z ve erkek \u00e7ocuklar i\u00e7in ilk dozu 11 veya 12 ya\u015f\u0131nda ve ikinci dozu, ilkinden alt\u0131 ila 12 ay sonra \u00f6nerir.<\/p>\n<p>15 ya\u015f ve \u00fcst\u00fc herkes i\u00e7in alt\u0131 ayl\u0131k bir s\u00fcre i\u00e7inde \u00fc\u00e7 at\u0131\u015f \u00f6nerilir. 12 ila 26 ya\u015flar\u0131 aras\u0131nda a\u015f\u0131 olmak en etkilidir. Ya\u015f\u0131n\u0131z ne olursa olsun, a\u015f\u0131n\u0131n size uygun olup olmad\u0131\u011f\u0131n\u0131 \u00f6\u011frenmek i\u00e7in doktorunuzla konu\u015fun.<\/p>\n<p>\u015eu anda insanlar\u0131n a\u015f\u0131 olmalar\u0131n\u0131n \u00f6n\u00fcndeki en b\u00fcy\u00fck engeller bilin\u00e7sizlik, sigorta kapsam\u0131n\u0131n olmamas\u0131 ve profesyonel <a href=\"\/tr\/article\/asi-tartismasi\/\">tavsiyeler<\/a>ve t\u0131bbi masraflar.<\/p>\n<p>\u00c7al\u0131\u015fman\u0131n k\u0131demli yazar\u0131 Ashish Deshmukh, &quot;HPV a\u015f\u0131s\u0131 kapsam\u0131, kaynaklar\u0131 k\u0131s\u0131tl\u0131 bir\u00e7ok \u00fclkede zay\u0131f a\u015f\u0131 al\u0131m oranlar\u0131 nedeniyle k\u00fcresel olarak 10%&#039;den daha az&quot; dedi. <a href=\"https:\/\/www.uth.edu\/news\/story.htm?id=19ae407d-0c3d-4f45-bbb2-9f9815d183f8\" target=\"_blank\" rel=\"noopener\">bas\u0131n b\u00fclteni.<\/a><\/p>\n<p>\u201cO\u011flanlar\u0131n ve k\u0131zlar\u0131n ilk dozlar\u0131n\u0131 almalar\u0131n\u0131 sa\u011flamak bir\u00e7ok \u00fclkede b\u00fcy\u00fck bir sorun ve ergenlerin \u00e7o\u011fu, iki veya \u00fc\u00e7 dozu uygulamak i\u00e7in gereken yo\u011fun altyap\u0131 eksikli\u011fi nedeniyle \u00f6nerilen serileri tamamlayam\u0131yor.<\/p>\n<p>Devam eden klinik deneyler, tek doz rejiminin s\u00fcrekli faydalar\u0131na dair kan\u0131t sa\u011fl\u0131yorsa, o zaman tek doz stratejisinin sonu\u00e7lar\u0131, bu kanserlerin y\u00fck\u00fcn\u00fc k\u00fcresel olarak azaltmak i\u00e7in \u00f6nemli olabilir.&quot;<\/p>\n<p>Bu bulgular, halen klinik deneylerde olmas\u0131na ra\u011fmen, \u00e7ok b\u00fcy\u00fck bir etkiye sahip olabilir. Yaln\u0131zca bir doza ihtiya\u00e7 duyulursa, k\u00fcresel olarak daha fazla n\u00fcfus a\u015f\u0131y\u0131 kar\u015f\u0131layabilecektir.<\/p>","protected":false},"excerpt":{"rendered":"<p>Yeni bir \u00e7al\u0131\u015fma, HPV a\u015f\u0131s\u0131n\u0131n etkinli\u011finin al\u0131nan doz say\u0131s\u0131yla \u00e7ok az ilgisi oldu\u011funu \u00f6ne s\u00fcr\u00fcyor. \u00d6nerilen seri her zaman iki veya \u00fc\u00e7 doz olmu\u015ftur,\u2026<\/p>","protected":false},"author":3,"featured_media":8039,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[774],"tags":[],"class_list":["post-8038","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-napoli-shkolnik-news"],"acf":[],"page_builder_type":"gutenberg","gutenberg_data":[],"_links":{"self":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/posts\/8038","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/comments?post=8038"}],"version-history":[{"count":0,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/posts\/8038\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/media\/8039"}],"wp:attachment":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/media?parent=8038"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/categories?post=8038"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/tags?post=8038"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}